nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—Metabolic alkalosis—Furosemide—dilated cardiomyopathy	0.0814	0.102	CcSEcCtD
Sodium stibogluconate—Nephrocalcinosis—Furosemide—dilated cardiomyopathy	0.0681	0.085	CcSEcCtD
Sodium stibogluconate—TOP1—cardiac ventricle—dilated cardiomyopathy	0.0396	0.317	CbGeAlD
Sodium stibogluconate—TOP1—myocardium—dilated cardiomyopathy	0.0373	0.298	CbGeAlD
Sodium stibogluconate—Tetany—Furosemide—dilated cardiomyopathy	0.0363	0.0452	CcSEcCtD
Sodium stibogluconate—Gastric irritation—Furosemide—dilated cardiomyopathy	0.0305	0.038	CcSEcCtD
Sodium stibogluconate—TOP1—heart—dilated cardiomyopathy	0.026	0.208	CbGeAlD
Sodium stibogluconate—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.0248	0.031	CcSEcCtD
Sodium stibogluconate—Ulcer—Spironolactone—dilated cardiomyopathy	0.023	0.0287	CcSEcCtD
Sodium stibogluconate—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.0225	0.028	CcSEcCtD
Sodium stibogluconate—TOP1—cardiac atrium—dilated cardiomyopathy	0.0223	0.178	CbGeAlD
Sodium stibogluconate—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0171	0.0213	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0168	0.229	CbGpPWpGaD
Sodium stibogluconate—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0143	0.0178	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—LMNA—dilated cardiomyopathy	0.0129	0.176	CbGpPWpGaD
Sodium stibogluconate—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0129	0.0161	CcSEcCtD
Sodium stibogluconate—Renal failure—Spironolactone—dilated cardiomyopathy	0.0119	0.0149	CcSEcCtD
Sodium stibogluconate—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0106	0.0132	CcSEcCtD
Sodium stibogluconate—Swelling—Furosemide—dilated cardiomyopathy	0.00972	0.0121	CcSEcCtD
Sodium stibogluconate—Oliguria—Lisinopril—dilated cardiomyopathy	0.00962	0.012	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00931	0.0116	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00921	0.125	CbGpPWpGaD
Sodium stibogluconate—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00861	0.0107	CcSEcCtD
Sodium stibogluconate—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00842	0.0105	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00837	0.0104	CcSEcCtD
Sodium stibogluconate—Irritability—Furosemide—dilated cardiomyopathy	0.00819	0.0102	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00804	0.01	CcSEcCtD
Sodium stibogluconate—Dehydration—Furosemide—dilated cardiomyopathy	0.00798	0.00995	CcSEcCtD
Sodium stibogluconate—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00793	0.0099	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—FASLG—dilated cardiomyopathy	0.00784	0.107	CbGpPWpGaD
Sodium stibogluconate—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00781	0.00974	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00775	0.00967	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—FAS—dilated cardiomyopathy	0.00756	0.103	CbGpPWpGaD
Sodium stibogluconate—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00746	0.00931	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00697	0.0087	CcSEcCtD
Sodium stibogluconate—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00676	0.00844	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00657	0.0082	CcSEcCtD
Sodium stibogluconate—Renal failure—Furosemide—dilated cardiomyopathy	0.0065	0.00811	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00646	0.00806	CcSEcCtD
Sodium stibogluconate—Urticaria—Spironolactone—dilated cardiomyopathy	0.00616	0.00768	CcSEcCtD
Sodium stibogluconate—Irritability—Lisinopril—dilated cardiomyopathy	0.00614	0.00767	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00613	0.00764	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00603	0.00752	CcSEcCtD
Sodium stibogluconate—Dehydration—Lisinopril—dilated cardiomyopathy	0.00599	0.00747	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00571	0.00712	CcSEcCtD
Sodium stibogluconate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00548	0.00684	CcSEcCtD
Sodium stibogluconate—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00547	0.00683	CcSEcCtD
Sodium stibogluconate—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00542	0.00676	CcSEcCtD
Sodium stibogluconate—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00535	0.00668	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0053	0.00662	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0053	0.00661	CcSEcCtD
Sodium stibogluconate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00512	0.00639	CcSEcCtD
Sodium stibogluconate—Flatulence—Furosemide—dilated cardiomyopathy	0.00509	0.00635	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00506	0.00631	CcSEcCtD
Sodium stibogluconate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00493	0.00615	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00489	0.0061	CcSEcCtD
Sodium stibogluconate—Rash—Spironolactone—dilated cardiomyopathy	0.00489	0.0061	CcSEcCtD
Sodium stibogluconate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00488	0.00609	CcSEcCtD
Sodium stibogluconate—Renal failure—Lisinopril—dilated cardiomyopathy	0.00488	0.00608	CcSEcCtD
Sodium stibogluconate—Vision blurred—Furosemide—dilated cardiomyopathy	0.00487	0.00607	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00486	0.00607	CcSEcCtD
Sodium stibogluconate—Headache—Spironolactone—dilated cardiomyopathy	0.00485	0.00606	CcSEcCtD
Sodium stibogluconate—Nausea—Spironolactone—dilated cardiomyopathy	0.0046	0.00574	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00422	0.00526	CcSEcCtD
Sodium stibogluconate—Shock—Furosemide—dilated cardiomyopathy	0.00415	0.00518	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00408	0.00509	CcSEcCtD
Sodium stibogluconate—Anorexia—Furosemide—dilated cardiomyopathy	0.00402	0.00501	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00398	0.00496	CcSEcCtD
Sodium stibogluconate—Hypotension—Furosemide—dilated cardiomyopathy	0.00394	0.00492	CcSEcCtD
Sodium stibogluconate—Flatulence—Lisinopril—dilated cardiomyopathy	0.00382	0.00477	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0038	0.00474	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00379	0.00472	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00366	0.00457	CcSEcCtD
Sodium stibogluconate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00365	0.00456	CcSEcCtD
Sodium stibogluconate—Fatigue—Furosemide—dilated cardiomyopathy	0.00363	0.00454	CcSEcCtD
Sodium stibogluconate—Constipation—Furosemide—dilated cardiomyopathy	0.00361	0.0045	CcSEcCtD
Sodium stibogluconate—Syncope—Lisinopril—dilated cardiomyopathy	0.00348	0.00434	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00345	0.0043	CcSEcCtD
Sodium stibogluconate—Palpitations—Lisinopril—dilated cardiomyopathy	0.00343	0.00427	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00341	0.00425	CcSEcCtD
Sodium stibogluconate—Urticaria—Furosemide—dilated cardiomyopathy	0.00335	0.00418	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00333	0.00416	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00333	0.00416	CcSEcCtD
Sodium stibogluconate—Chest pain—Lisinopril—dilated cardiomyopathy	0.0033	0.00412	CcSEcCtD
Sodium stibogluconate—Anxiety—Lisinopril—dilated cardiomyopathy	0.00329	0.0041	CcSEcCtD
Sodium stibogluconate—TOP1—Caspase Cascade in Apoptosis—TNF—dilated cardiomyopathy	0.00321	0.0437	CbGpPWpGaD
Sodium stibogluconate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00316	0.00395	CcSEcCtD
Sodium stibogluconate—Oedema—Lisinopril—dilated cardiomyopathy	0.00316	0.00395	CcSEcCtD
Sodium stibogluconate—Infection—Lisinopril—dilated cardiomyopathy	0.00314	0.00392	CcSEcCtD
Sodium stibogluconate—Shock—Lisinopril—dilated cardiomyopathy	0.00311	0.00388	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00311	0.00388	CcSEcCtD
Sodium stibogluconate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00309	0.00385	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00306	0.00382	CcSEcCtD
Sodium stibogluconate—Asthenia—Furosemide—dilated cardiomyopathy	0.00302	0.00377	CcSEcCtD
Sodium stibogluconate—Anorexia—Lisinopril—dilated cardiomyopathy	0.00302	0.00376	CcSEcCtD
Sodium stibogluconate—Pruritus—Furosemide—dilated cardiomyopathy	0.00298	0.00372	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00298	0.0406	CbGpPWpGaD
Sodium stibogluconate—Hypotension—Lisinopril—dilated cardiomyopathy	0.00296	0.00369	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00288	0.0036	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00287	0.0391	CbGpPWpGaD
Sodium stibogluconate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00284	0.00354	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00282	0.00352	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00282	0.0384	CbGpPWpGaD
Sodium stibogluconate—Dizziness—Furosemide—dilated cardiomyopathy	0.00279	0.00348	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00276	0.0376	CbGpPWpGaD
Sodium stibogluconate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00275	0.00343	CcSEcCtD
Sodium stibogluconate—Fatigue—Lisinopril—dilated cardiomyopathy	0.00273	0.0034	CcSEcCtD
Sodium stibogluconate—Constipation—Lisinopril—dilated cardiomyopathy	0.00271	0.00338	CcSEcCtD
Sodium stibogluconate—Vomiting—Furosemide—dilated cardiomyopathy	0.00268	0.00334	CcSEcCtD
Sodium stibogluconate—Rash—Furosemide—dilated cardiomyopathy	0.00266	0.00332	CcSEcCtD
Sodium stibogluconate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00266	0.00331	CcSEcCtD
Sodium stibogluconate—Headache—Furosemide—dilated cardiomyopathy	0.00264	0.0033	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00259	0.00323	CcSEcCtD
Sodium stibogluconate—Urticaria—Lisinopril—dilated cardiomyopathy	0.00251	0.00314	CcSEcCtD
Sodium stibogluconate—Nausea—Furosemide—dilated cardiomyopathy	0.0025	0.00312	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0025	0.00312	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.0025	0.00312	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00233	0.00291	CcSEcCtD
Sodium stibogluconate—Asthenia—Lisinopril—dilated cardiomyopathy	0.00227	0.00283	CcSEcCtD
Sodium stibogluconate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00224	0.00279	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00216	0.0027	CcSEcCtD
Sodium stibogluconate—Dizziness—Lisinopril—dilated cardiomyopathy	0.00209	0.00261	CcSEcCtD
Sodium stibogluconate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00201	0.00251	CcSEcCtD
Sodium stibogluconate—Rash—Lisinopril—dilated cardiomyopathy	0.00199	0.00249	CcSEcCtD
Sodium stibogluconate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00199	0.00249	CcSEcCtD
Sodium stibogluconate—Headache—Lisinopril—dilated cardiomyopathy	0.00198	0.00247	CcSEcCtD
Sodium stibogluconate—Nausea—Lisinopril—dilated cardiomyopathy	0.00188	0.00234	CcSEcCtD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00187	0.0254	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.00128	0.0175	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00122	0.0166	CbGpPWpGaD
